IsoRay, Inc. (ISR) financial statements (2021 and earlier)

Company profile

Business Address 350 HILLS STREET,
RICHLAND, WA 99354
State of Incorp. MN
Fiscal Year End June 30
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
3/31/2019
Q3
12/31/2018
Q2
9/30/2018
Q1
6/30/2018
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3556893
Cash and cash equivalents3554323
Short-term investments   2571
Receivables1211111
Inventory, net of allowances, customer advances and progress billings1111000
Inventory1111000
Prepaid expense  0   0
Other current assets  0   0
Other undisclosed current assets0000010
Total current assets:677810115
Noncurrent Assets
Inventory, Noncurrent0000000
Operating lease, right-of-use asset11  
Property, plant and equipment2222111
Restricted cash and investments0000000
Other noncurrent assets0000000
Total noncurrent assets:3322222
TOTAL ASSETS:91091112137
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1111111
Employee-related liabilities0000000
Other undisclosed accounts payable and accrued liabilities0111111
Debt00     
Other liabilities0000000
Other undisclosed current liabilities0000000
Total current liabilities:1211222
Noncurrent Liabilities
Long-term debt and lease obligation11     
Operating lease, liability11  
Liabilities, other than long-term debt1111111
Asset retirement obligations1111111
Total noncurrent liabilities:1211111
Total liabilities:3322222
Stockholders' equity
Stockholders' equity attributable to parent678910115
Common stock0000000
Additional paid in capital92929292929284
Accumulated deficit(86)(85)(84)(83)(82)(81)(79)
Total stockholders' equity:678910115
TOTAL LIABILITIES AND EQUITY:91091112137

Income statement (P&L) ($ in millions)

12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
3/31/2019
Q3
12/31/2018
Q2
9/30/2018
Q1
6/30/2018
Q4
Revenues2222222
Cost of revenue
(Cost of Goods and Services Sold)
(1)(1)(1)(1)(1)(1)(1)
Gross profit:1111110
Operating expenses(2)(2)(2)(2)(2)(2)(3)
Operating loss:(1)(1)(1)(1)(1)(2)(2)
Nonoperating income0000000
Investment income, nonoperating0000000
Net loss attributable to parent:(1)(1)(1)(1)(1)(2)(2)
Preferred stock dividends and other adjustments(0)(0)(0)(0)(0)(0)(0)
Net loss available to common stockholders, diluted:(1)(1)(1)(1)(1)(2)(2)

Comprehensive Income ($ in millions)

12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
3/31/2019
Q3
12/31/2018
Q2
9/30/2018
Q1
6/30/2018
Q4
Net loss:(1)(1)(1)(1)(1)(2)(2)
Comprehensive loss, net of tax, attributable to parent:(1)(1)(1)(1)(1)(2)(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: